RealPennies.com: Turning Pennies into dollars: (NASDAQ: PHRM); (OTCBB: UDHI); (OTCBB: ARRT).

0 Comments | M2 Presswire, February, 2008

M2 PRESSWIRE-15 February 2008-RealPennies.com: RealPennies.com: Turning Pennies into dollars: (NASDAQ: PHRM); (OTCBB: UDHI); (OTCBB: ARRT).(C)1994-2008 M2 COMMUNICATIONS LTD

RDATE:15022008

Are you a public company looking for exposure? Contact RealPennies.com - 1.800.940.6559

For more info: http://phrm.realpennies.com

MethylGene Inc. (TSX: MYG) and Pharmion Corporation (NASDAQ: PHRM)(February 14, 2008)announced that the U.S. Food and Drug Administration (FDA) has designated the Companies' histone deacetylase (HDAC) inhibitor, MGCD0103, as an Orphan Drug for the treatment of acute myelogenous leukemia (AML) in the United States. Criteria for designation require that the product be intended for treatment of a condition affecting...